Briefing

AusSMC BRIEFING: Get in quick: clinical trial supports early HIV treatment

Publicly released:
Australia; NSW
HIV budding off a lymphocyte
HIV budding off a lymphocyte

BRIEFING TIME: Tuesday 26 MAY at 12:00 noon AEST ONLINE. An international HIV treatment trial has been terminated after interim results provided conclusive evidence that immediate treatment of HIV is superior to the current practice of deferring treatment among people with HIV infection.

Media release

From:

NEWS BRIEFING – Tuesday 26 May 2015 at 12:00 noon AEST online.

An international HIV treatment trial has been terminated after interim results provided conclusive evidence that immediate treatment of HIV is superior to the current practice of deferring treatment among people with HIV infection. These findings have global implications for the treatment of people living with HIV, as we now know that treatment at all stages of disease extends survival and prevents serious disease complications. Together with data from previous studies showing reduced risk of HIV transmission among people on Antiretroviral Therapy (ART), our speaker will discuss how the clinical trial findings are critical in supporting treatment for victims of HIV at any stage infection, and accordingly, will influence treatment regimens for the HIV virus worldwide.

The briefing will discuss the following issues:

  • The START trial: Methodology, findings and implications for international treatment guidelines for HIV infection.

SPEAKERS:

  • Professor Sean Emery, co-ordinating investigator of the START study from the Kirby Institute at UNSW Australia. 

DATE: Tuesday 26 May 2015
START TIME: 12:00 noon AEST 
DURATION: Approx 30 min
 VENUE: Online

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Media Release The Kirby Institute for Infection and Immunity in Society PDF , 127.7 KB
Other Australian Science Media Centre, Web page You can find a copy of the briefing here
Journal/
conference:
Organisation/s: The Kirby Institute for Infection and Immunity in Society, The University of New South Wales
Funder:
Media Contact/s
Contact details are only visible to registered journalists.